In addition, the Sig-1R agonist PRE-084 can alleviate the pathological and behavioral defects in experimental models of Parkinson's disease (PD) and ALS via upregulating neurotrophic factors or restoring Sig-1R's functions [25, 29]. The gene discussed is SIGMAR1; the disease is amyotrophic lateral sclerosis.